Skip to main content

Align Technology Expands Digital Platform With Cloud-Based ClinCheck™ Pro 6.0 and ClinCheck “In-Face” Visualization for Invisalign Treatment

Written by Customer Service on . Posted in Public Companies.

New ClinCheck software moves digital treatment planning to the cloud for access anywhere, on any device
Powerful new tool aids digital treatment planning and helps patients visualize personalized treatment outcomes using their photos and 3D modelsSAN JOSE, Calif. and LONDON, May 14, 2020 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) today introduced the latest version of its proprietary ClinCheck treatment planning software at the Invisalign Scientific Symposium, a fully digital event for Invisalign-trained orthodontists. ClinCheck software provides doctors with a 3D model of planned tooth movements throughout the Invisalign treatment. ClinCheck Pro 6.0 moves Invisalign digital treatment planning to the cloud, making its robust ClinCheck treatment planning tools and features available to doctors anytime, anywhere, on any laptop, personal computer or tablet. The release includes the new ClinCheck “In-Face” Visualization tool, an enhanced doctor-facing digital clinical tool that combines a photo of the patient’s face with their 3D Invisalign treatment plan, creating a personalized view of how their new smile could look.ClinCheck “In-Face” Visualization is designed to help doctors with their digital treatment planning and to increase patient understanding of the benefits provided by Invisalign treatment through enhanced visualizations of their personalized treatment outcome. The ClinCheck “In-Face” Visualization workflow combines three components of Align’s digital treatment platform: Invisalign Photo Uploader for patient photos, the iTero intraoral scanner to capture data needed for the 3D model of the patient’s dentition, and ClinCheck Pro 6.0.“Cloud-based ClinCheck Pro 6.0 and ClinCheck ‘In-Face’ Visualization are the latest components of the end-to-end digital treatment platform we provide to doctors,” said Raj Pudipeddi, Align’s chief innovation, product, and marketing officer and SVP. “They represent important advancements in our industry leading digital platform – the convenience and accessibility of cloud-based computing and the power of visualization. Being able to merge a 2D facial photo and 3D treatment plan to show patients a personalized view of their planned treatment outcome is an incredible tool for doctors in terms of treatment acceptance. ClinCheck Pro 6.0 and ClinCheck ‘In-Face’ Visualization are the first in what we intend to be a series of innovations to reimagine our digital treatment planning experience for doctors. The experience and know-how from treating more than 8 million Invisalign patients enables us to continually improve our treatment planning process and helps maintain our position as a market leader.”“ClinCheck ‘In-Face’ Visualization is a game-changer for doctor treatment planning and for interacting with my patients in my digital practice,” said Dr. Ahmad Hagar, an Invisalign trained doctor practicing in Freiburg, Germany. “Being able to see a new, straighter version of their teeth in a photo of themselves creates a powerful emotional connection for the patient. We’re no longer just planning and showing them how we will move teeth; we’re showing them how their smile could be transformed through Invisalign treatment.”In addition to ClinCheck “In-Face” Visualization, ClinCheck Pro 6.0 offers users a treatment planning solution that provides doctors with a more intuitive design and an enhanced user experience. This includes improvements to allow doctor modifications through 3D controls and new education features such as dynamic tool tips and product tour. Finally, the cloud-based solution allows doctors to treatment plan with flexibility across devices and ensures that they have the latest version of the software without the need for additional downloads.Doctors will access ClinCheck Pro 6.0 by logging on to their Invisalign Doctor Site to access patient files – there is no need to download or install an application. ClinCheck Pro 6.0 with “In-Face” Visualization will be available starting in the third quarter of 2020.For more details about the Invisalign Scientific Symposium including times, and details about how to sign up to participate, visit: www.invisalignscientificsymposium.com.About Align Technology, Inc.Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and CAD/CAM software. Align has helped treat over 8 million patients with the Invisalign system and is driving the evolution in digital dentistry with the iTero intraoral scanner and exocad CAD/CAM software − modernizing today’s practices by enabling enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies. Visit www.aligntech.com for more information.For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.